HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients

被引:1
作者
Sanguinetti, SM [1 ]
Brites, FD [1 ]
Fasulo, V [1 ]
Verona, J [1 ]
Elbert, A [1 ]
Wikinski, RLW [1 ]
Schreier, LE [1 ]
机构
[1] Univ Buenos Aires, Fac Farm & Bioquim, Dept Bioquim Clin, RA-1113 Buenos Aires, DF, Argentina
关键词
high density lipoprotein; low density lipoprotein; lipoprotein oxidation; Type; 2; diabetes; paraoxonase;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Low density lipoprotein (LDL) oxidation is a crucial step in the atherosclerotic process. High density lipoprotein (HDL)-associated enzymes such as paraoxonase could exert a protective effect on LDL oxidation in the arterial wall, an effect which could be impaired in Type 2 diabetes mellitus (T2DM). We studied copper-induced oxidation in LDL and HDL isolated from 17 T2DM patients with fair glycaemic control and HDL-cholesterol within normal range and 17 healthy normolipidaemic control subjects. To evaluate the effect of HDL on LDL oxidation in diabetic and control subjects, we assessed copper-induced oxidation in HDL/LDL mixtures, with each lipoprotein isolated from the same subject. Relationships with HDL chemical composition, a-tocopherol content and serum paraoxonase activity were investigated. Oxidation was promoted by lipoprotein incubation with copper and then thiobarbituric acid reactive substances (TBARS), conjugated diene production and electrophoretic mobility in agarose gel were measured. In T2DM subjects HDL oxidation was higher than in controls. However, HDL from diabetics was as effective as control HDL to inhibit LDL oxidation, Neither HDL chemical composition nor serum paraoxonase activity showed any difference as compared to control subjects. In contrast, HDL from T2DM subjects showed a higher a-tocopherol content which positively correlated with HDL oxidability. Paraoxonase activity positively and strongly correlated with HDL inhibitory effect on LDL oxidation in patients and controls belonging to the heterozygous activity phenotype, Besides, LDL oxidability showed no differences between patients and controls. These results suggest that fairly-controlled T2DM patients with HDL-cholesterol levels within normal range show: 1) normal HDL ability to inhibit LDL oxidation related to normal paraoxonase activity; 2) higher HDL oxidability in spite of its high a-tocopherol content, which could favour tocopherol-mediated peroxidation and 3) normal LDL oxidability possibly due to the lack of significant lipoprotein structural alterations. (C) 2001, Editrice Kurtis.
引用
收藏
页码:27 / 36
页数:10
相关论文
共 44 条
  • [1] SERUM PARAOXONASE ACTIVITY, CONCENTRATION, AND PHENOTYPE DISTRIBUTION IN DIABETES-MELLITUS AND ITS RELATIONSHIP TO SERUM-LIPIDS AND LIPOPROTEINS
    ABBOTT, CA
    MACKNESS, MI
    KUMAR, S
    BOULTON, AJ
    DURRINGTON, PN
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (11) : 1812 - 1818
  • [2] ASSMANN G, 1983, CLIN CHEM, V29, P2026
  • [3] LDL-CHOLESTEROL DETERMINATION IN BLOOD-SERUM FOLLOWING PRECIPITATION OF LDL WITH POLYVINYLSULFATE
    ASSMANN, G
    JABS, HU
    KOHNERT, U
    NOLTE, W
    SCHRIEWER, H
    [J]. CLINICA CHIMICA ACTA, 1984, 140 (01) : 77 - 83
  • [4] Does paraoxonase play a role in susceptibility to cardiovascular disease?
    Aviram, M
    [J]. MOLECULAR MEDICINE TODAY, 1999, 5 (09): : 381 - 386
  • [5] Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions - A possible peroxidative role for paraoxonase
    Aviram, M
    Rosenblat, M
    Bisgaier, CL
    Newton, RS
    Primo-Parmo, SL
    La Du, BN
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (08) : 1581 - 1590
  • [6] BANKA C, 1995, CURR OPIN LIPIDOL, V7, P139
  • [7] BARTLETT GR, 1959, J BIOL CHEM, V234, P466
  • [8] HIGH-DENSITY-LIPOPROTEIN IS THE MAJOR CARRIER OF LIPID HYDROPEROXIDES IN HUMAN BLOOD-PLASMA FROM FASTING DONORS
    BOWRY, VW
    STANLEY, KK
    STOCKER, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) : 10316 - 10320
  • [9] Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels
    Brites, FD
    Bonavita, CD
    De Geitere, C
    Cloës, M
    Delfly, B
    Yael, MJ
    Fruchart, JC
    Wikinski, RW
    Castgro, GR
    [J]. ATHEROSCLEROSIS, 2000, 152 (01) : 181 - 192
  • [10] CHRISTISON JK, 1995, J LIPID RES, V36, P2017